🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

48 results for “methotrexate” Clear

  1. JNJ-73841937, Montelukast Sodium Tablets, Dexamethason 4 mg JENAPHARM®, Methotrexat-Ebewe, 10mg/ml, roztwór do wstrzykiwań, JNJ-61186372, Methotrexate

    Janssen-Cilag International N.V.

    EGFR-mutated Advanced or Metastatic Non-small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  2. MERCAPTOPURINE, PREDNISONE, VINCRISTINE SULFATE, CYTARABINE, FILGRASTIM, LENOGRASTIM, CYTARABINE, IDARUBICIN HYDROCHLORIDE, FOLINIC ACID, Iclusig 15 mg film-coated tablets, METHYLPREDNISOLONE SODIUM SUCCINATE, CYCLOPHOSPHAMIDE, METHOTREXATE, METHOTREXATE, DEXAMETHASONE DISODIUM PHOSPHATE, Iclusig 15 mg film-coated tablets

    Fondazione Telethon ETS

    Adult Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia.

    phase 2 small molecule active

    1 trial

  3. Match placebo to test product, METHOTREXATE , SAR441566, SAR441566

    Sanofi Pharma Bristol-Myers Squibb

    Rheumatoid arthritis

    phase 2 small molecule active

    1 trial

  4. Methotrexate

    China SXT Pharmaceuticals

    Primary Central Nervous System Lymphoma

    phase 2 small molecule active

    1 trial

  5. Methotrexate tablets

    First Tracks Biotherapeutics

    Solid Tumors

    phase 2 small molecule active

    1 trial

  6. PONATINIB, CYCLOPHOSPHAMIDE, VINCRISTINE, BESPONSA 1 mg powder for concentrate for solution for infusion, METHOTREXATE, PURINETHOL 50 mg compresse, PREDNISONE

    Fondazione Telethon ETS

    Acute B-cell Lymphoblastic Leukemia with minimal residual positive disease prior to haematopoietic stem cell transplantation in adult patients

    phase 2 small molecule active

    1 trial

  7. TAK-715 and methotrexate

    Takeda Pharmaceuticals International AG

    Arthritis, Rheumatoid

    phase 2 small molecule completed

    1 trial

  8. TAK-783 and methotrexate

    Takeda Pharmaceuticals International AG

    Arthritis, Rheumatoid

    phase 2 small molecule completed

    1 trial

  9. TEMOZOLOMIDE, TEMOZOLOMIDE, TOCILIZUMAB, CALCIUM FOLINATE, CYCLOPHOSPHAMIDE, RITUXIMAB, Lisocabtagene maraleucel, TEMOZOLOMIDE, PROCARBAZINE, FLUDARABINE, METHOTREXATE, TEMOZOLOMIDE, CALCIUM FOLINATE

    Bristol-Myers Squibb / Pfizer EEIG

    Primary Central Nervous System Lymphoma

    phase 2 small molecule active

    1 trial

  10. Thalidomide and methotrexate

    China SXT Pharmaceuticals

    T-LGL Leukemia

    phase 2 small molecule active

    1 trial

  11. Dose dense re-challenge of high dose methotrexate (hd-mtx) with glucarpidase (cpg2) for relapsed primary cns lymphoma (pcnsl): A phase 1 trial (METHOGLU)

    Pari Pharma GmbH

    Oncology: RELAPSED PRIMARY CNS LYMPHOMA

    phase 1 other active

    1 trial

  12. Methotrexate

    Sana Biotechnology

    Chronic Plaque Psoriasis

    phase 1 small molecule active

    1 trial

  13. Methotrexate - Amneal

    Amneal Pharma Europe Ltd

    Psoriasis

    phase 1 small molecule active

    1 trial

  14. Methotrexate PK (in combination with Novobiocin) in RA patients

    Pharma Mar S.A.

    Rheumatoid arthritis

    phase 1 other active

    1 trial

  15. Single agent of cyclophosphamide, doxorubicin, epirubicin, fluorouracil and methotrexate

    China SXT Pharmaceuticals

    Breast Cancer

    phase 1 small molecule active

    1 trial

  16. HYDROXYCHLOROQUINE , ABATACEPT , AZATHIOPRINE , SULFASALAZINE , METHOTREXATE , Cimzia 200 mg solution for injection in pre-filled syringe, LEFLUNOMIDE, RoActemra 162 mg solution for injection in pre-filled syringe., RoActemra 20 mg/mL concentrate for solution for infusion, PREDNISOLONE , Triamcinolone Hexacetonide 20 mg/ml suspension for injection, METHOTREXATE

    Institut für biomedizinische Analytik NMR-Imaging GmbH

    Rheumatoid Arthritis

    approved small molecule active

    1 trial

  17. METHOTREXATE , MYCOPHENOLIC ACID , AZATHIOPRINE , Tavneos 10 mg hard capsules, CYCLOPHOSPHAMIDE , -, RITUXIMAB, Placebo for AMG 569

    Amgen Technology (Ireland) UC

    Antineutrophil cytoplasmic antibody-associated vasculitis (AAV)

    approved small molecule active

    1 trial

  18. METHOTREXATE, METHOTREXATE, PREDNISONE, METHOTREXATE

    Disc Medicine

    Pulmonary sarcoidosis

    approved small molecule active

    1 trial

  19. Methotrexate

    United Therapeutics Europe Ltd

    Psoriatic Arthritis

    approved small molecule completed

    1 trial

  20. Methotrexate 2,5 mg film-coated tablets, Simponi 50 mg solution for injection in pre-filled syringe., Hydroxychloroquine sulfate 200mg film-coated Tablets, Cimzia 200 mg solution for injection in pre-filled syringe, Depo-Medrol 80 mg/2 ml Injektionssuspension, Leflunomide Aurobindo 20 mg compresse rivestite con film, Enbrel 50 mg solution for injection in pre-filled syringe, Humira 40 mg solution for injection in pre-filled syringe, Sulfasalazine 500 mg Tablets, Jyseleca 200 mg film-coated tablets, Kenacort

    Disc Medicine

    Rheumatoid arthritis according to 2010 criteria

    approved small molecule active

    1 trial

  21. Methotrexate

    First Tracks Biotherapeutics

    Knee Osteoarthritis

    small molecule completed

    1 trial

  22. Rituximab, Methotrexate, and Thiotepa (R-MT) Induction Followed by Etoposide and Cytarabine (EA) Consolidation

    First Tracks Biotherapeutics

    Primary Central Nervous System Lymphoma (PCNSL)

    small molecule active

    1 trial

  23. Ruxolitinib+Calcineurin inhibitor+Methotrexate

    First Tracks Biotherapeutics

    Graft Versus Host Disease

    small molecule completed

    1 trial

  24. methotrexate

    INTEGRATED BIOPHARMA INC

    Rheumatoid Arthritis

    small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources